| Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month AS Bourinbaiar, U Batbold, Y Efremenko, M Sanjagdorj, D Butov, ... Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 18, 100141, 2020 | 34 | 2020 |
| Randomized, Placebo-Controlled Phase II Trial of Heat-Killed Mycobacterium Vaccae(Immodulon Batch) Formulated as an Oral Pill (V7) DA Butov, YV Efremenko, ND Prihoda, SI Zaitzeva, LV Yurchenko, ... Immunotherapy 5 (10), 1047-1054, 2013 | 31 | 2013 |
| Association of interleukins genes polymorphisms with multi-drug resistant tuberculosis in Ukrainian population D Butov, M Kuzhko, N Makieieva, T Butova | 30 | 2016 |
| Phase IIb randomized trial of adjunct immunotherapy in patients with first-diagnosed tuberculosis, relapsed and multi-drug-resistant (MDR) TB DA Butov, YN Pashkov, AL Stepanenko, AI Choporova, TS Butova, ... Journal of immune based therapies and vaccines 9, 1-9, 2011 | 30 | 2011 |
| Treatment of cavitary and infiltrating pulmonary tuberculosis with and without the immunomodulator Dzherelo SI Zaitzeva, SL Matveeva, TG Gerasimova, YN Pashkov, DA Butov, ... Clinical Microbiology and Infection 15 (12), 1154-1162, 2009 | 30 | 2009 |
| Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7) YV Efremenko, DA Butov, ND Prihoda, SI Zaitzeva, LV Yurchenko, ... Human vaccines & immunotherapeutics 9 (9), 1852-1856, 2013 | 28 | 2013 |
| Efficacy and safety of quercetin and polyvinylpyrrolidone in treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard … D Butov, S Zaitseva, T Butova, G Stepanenko, O Pogorelova, ... International journal of mycobacteriology 5 (4), 446-453, 2016 | 27 | 2016 |
| Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine D Butov, C Lange, J Heyckendorf, I Kalmykova, T Butova, N Borovok, ... The International Journal of Tuberculosis and Lung Disease 24 (5), 485-491, 2020 | 25 | 2020 |
| Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIV DA Butov, YV Efremenko, ND Prihoda, LI Yurchenko, NI Sokolenko, ... Immunotherapy 4 (7), 687-695, 2012 | 25 | 2012 |
| Immune approaches in tuberculosis therapy: a brief overview AS Bourinbaiar, MV Mezentseva, DA Butov, PS Nyasulu, YV Efremenko, ... Expert review of anti-infective therapy 10 (3), 381-389, 2012 | 25 | 2012 |
| Assessing the Cytotoxicity of TiO2−x Nanoparticles with a Different Ti3+(Ti2+)/Ti4+ Ratio V Prokopiuk, S Yefimova, A Onishchenko, V Kapustnik, V Myasoedov, ... Biological trace element research 201 (6), 3117-3130, 2023 | 24 | 2023 |
| National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022 D Butov, Y Feshchenko, D Chesov, VV Myasoedov, M Kuzhko, A Dudnyk, ... International Journal of Tuberculosis and Lung Disease, 86-88, 2023 | 24 | 2023 |
| UV Light-Activated GdYVO4:Eu3+ Nanoparticles Induce Reactive Oxygen Species Generation in Leukocytes Without Affecting Erythrocytes In Vitro A Onishchenko, V Myasoedov, S Yefimova, O Nakonechna, V Prokopyuk, ... Biological trace element research, 1-16, 2022 | 24 | 2022 |
| Food additive E407a stimulates eryptosis in a dose-dependent manner A Tkachenko, Y Kot, V Prokopyuk, A Onishchenko, A Bondareva, ... Wiener Medizinische Wochenschrift 172 (5), 135-143, 2022 | 23 | 2022 |
| Treatment effectiveness and outcome in patients with a relapse and newly diagnosed multidrug-resistant pulmonary tuberculosis D Butov, V Myasoedov, M Gumeniuk, G Gumeniuk, O Choporova, ... Medicinski glasnik, 2020 | 19 | 2020 |
| Association between effectiveness of tuberculosis treatment and cytochrome P-4502E1 polymorphism of the patients P Antonenko, D Butov, V Kresyun, K Antonenko, T Butova The International Journal of Mycobacteriology 6 (4), 396-400, 2017 | 15 | 2017 |
| Double-blind, placebo-controlled, 1: 1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis U Batbold, DO Butov, GA Kutsyna, N Damdinpurev, EA Grinishina, ... Immunotherapy 9 (1), 13-24, 2017 | 14 | 2017 |
| Changes in nitric oxide synthase and nitrite and nitrate serum levels in patients with or without MDR-TB undergoing the intensive phase of anti-tuberculosis therapy DO Butov, MM Kuzhko, IM Kalmykova, IM Kuznetsova, TS Butova, ... The International Journal of Mycobacteriology 3 (2), 139-143, 2014 | 14 | 2014 |
| MDR-TB in Eastern Europe in the era of the TB elimination action framework A Dudnyk, D Butov, V Krudu, CG Lange, D Chesov International Journal of Tuberculosis and Lung Disease 21 (1), 2-3, 2017 | 13 | 2017 |
| Morphological changes in experimental tuberculosis resulting from treatment with quercetin and polyvinylpyrrolidone DO Butov, SI Zaitseva, MM Pitenko, GL Stepanenko, TS Butova International journal of mycobacteriology 4 (4), 296-301, 2015 | 13 | 2015 |
